Epidermal growth factor and transforming growth factor-α-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3590-3597

  Ramljak, Danica ^a   Jones, Ann B ^a   Diwan, Bhalchandra A ^b   Perantoni, Alan O ^a   Hochadel, James F ^b   Anderson, Lucy M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR; MYC PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CHRONIC ACTIVE HEPATITIS; CONTROLLED STUDY; GENE OVEREXPRESSION; HELICOBACTER; HELICOBACTER HEPATICUS; LIVER CARCINOGENESIS; LIVER CARCINOMA; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION;

ANIMALS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; EPIDERMAL GROWTH FACTOR; HELICOBACTER INFECTIONS; HEPATITIS, ANIMAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED A; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0032529427     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ward, J. M., Fox, J. G., Anver, M. R., Haines, D. C., George, C. V., Collins, M. J., Jr., Gorelick, P. L., Nagashima, K., Gonda, M. A., Gilden, R. V., Tully, J. G., Russell, R. J., Benveniste, R. E., Paster, B. J., Dewhirst, F. E., Donovan, J. C., Anderson, L. M., and Rice, J. M. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. (Bethesda), 86: 1222-1227, 1994.
2. Fox, J. G., Dewhirst, F. E., Tully, J. G., Paster, B. J., Yan, L., Taylor, N. S., Collins, M. J., Jr., Gorelick, P. L., and Ward, J. M. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol., 32: 1238-1245, 1994.
3. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans: Schistosomes, Liver Flukes and Helicobacter pylori, IARC Scientific Publ. No. 61, pp. 1-239. Lyon, France: IARC, 1994.
4. Sipowicz, M. A., Weghorst, C. M., Shiao, Y-H., Buzard, G. S., Calvert, R. J., Anver, M. R., Anderson, L. M., and Rice, J. M. Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice. Carcinogenesis (Lond.), 18: 233-236, 1997.
5. Canella, K. A., Diwan, B. A., Gorelick, P. L., Donovan, P. J., Sipowicz, M. A., Kasprzak, K. S., Weghorst, C. M., Snyderwine, E. G., Davis, C. D., Keefer, L. K., Kyrtopoulos, S. A., Hecht, S. S., Wang, M., Anderson, L. M., and Rice, J. M. Liver tumorigenesis by Helicobacter hepaticus: considerations of mechanism. In Vivo, 10: 285-292, 1996.
6. Diwan, B. A., Ward, J. M., Ramljak, D., and Anderson, L. M. Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodi-methylamine in male A/JCr mice. Toxicol. Pathol., 25: 65-73, 1997.
7. Mead, J. E., and Fausto, N. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA, 86: 1558-1562, 1989.
8. Michalopoulos, G. K., and DeFrances, M. C. Liver regeneration. Science (Washington DC), 276: 60-66, 1997.
9. Takagi, H., Sharp, R., Takayama, H., Anver, M. R., Ward, J. M., and Merlino, G. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor α transgenic mice. Cancer Res., 53: 4329-4336, 1993.
10. Burr, A. W., Toole, K., Mathew, J., Hines, J. E., Chapman, C., and Burt, A. D. Transforming growth factor-α expression is altered during experimental hepatocarcinogenesis. J. Pathol., 179: 276-282, 1996.
11. Woitach, J. T., Conner, E. A., Wirth, P. J., and Thorgeirsson, S. S. Aberrant expression and regulation of hepatic epidermal growth factor receptor in a c-myc transgenic mouse model. J. Cell. Biochem., 64: 651-660, 1997.
12. Burr, A. W., Hillan, K. J., McLaughlin, K. E., Ferrier, R., Chapman, C., Mathew, J., and Burt, A. D. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. Hepatology, 24: 1282-1287, 1996.
13. Kuniyasu, H., Yasui, W., Shimamoto, F., Fujii, K., Nakahara, M., Asahara, T., Dohi, K., and Tahara, E. Hepatoblastoma in an adult associated with c-met proto-oncogene imbalance. Pathol. Int., 46: 1005-1010, 1996.
14. 1 checkpoint. Mol. Cell. Biol., 16: 6917-6925, 1996.
15. Nishida, N., Fukuda, Y., Komeda, T., Kita, R., Sando, T., Furukawa, M., Amenomori, M., Shibagaki, I., Nakao, K., Ikenaga, M., and Ishizaki, K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res., 54: 3107-3110, 1994.
16. Bartek, J., Bartkova, J., and Lukas, J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell. Biol., 8: 805-814, 1996.
17. Meichle, A., Philipp, A., and Eilers, M. The functions of Myc proteins. Biochim. Biophys. Acta, 1114: 129-146, 1992.
18. Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., and Penn, L. J. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogenstimulated signal transduction to the cell cycle. Oncogene, 9: 3635-3645, 1994.
19. Ren, G-J., Hu, L-F., Cheng, Y-C., and Wan, D-F. J. Oncogenes in human primary cancer. Cell. Physiol. Suppl., 4: 13-21, 1986.
20. Chandar, N., Lombardi, B., and Locker, J. c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc. Natl. Acad. Sci. USA, 86: 2703-2707, 1989.
21. Nagy, P., Evarts, R. P., Marsden, E., Roach, J., and Thorgeirsson, S. S. Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats. Cancer Res., 48: 5522-5527, 1998.
22. 1 and S phases of adult rat hepatocytes in vitro. J. Biol. Chem., 271: 11484-11492, 1996.
23. 1 cyclin-cdk complexes. EMBO J., 14: 4814-4826, 1995.
24. INK4A as upstream regulators of Myc. Oncogene, 15: 179-192, 1997.
25. Robles, A. I., and Conti, C. J. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis (Lond.), 16: 781-786, 1995.
26. Journe, F., Wattiez, R., Piron, A., Carion, M., Laurent, G., Heuson-Stiennon, J-A., and Falmagne, P. Renal epidermal growth factor precursor: preoteolytic processing in an in vitro cell-free system. Biochim. Biophys. Acta, 1357: 18-30, 1997.
27. Murakami, H., Sanderson, N. D., Nagy, P., Marino, P. A., Merlino, G., and Thorgeirsson, S. S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res., 53: 1719-1723, 1993.
28. Roussel, M. F., Theodoras, A. M., Pagano, M., and Sherr, C. J. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA, 92: 6837-6841, 1995.
29. Santoni-Rugiu, E., Jensen, M. R., and Thorgeirsson, S. S. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α. Cancer Res., 58: 123-134, 1998.
30. Fujimoto, Y. Aberrations of tumor suppressor genes in hepatocellular carcinomas. Hokkaido Igaku Zasshi, 69: 1252-1260, 1994.
31. Romach, E. H., Goldsworthy, T. L., Maronpot, R. R., and Fox, T. R. Altered gene expression in spontaneous hepatocellular carcinomas from male B6C3F1 mice. Mol. Carcinog., 19: 31-38, 1997.
32. Dobashi, Y., and Stern, D. F. Membrane-anchored forms of EGF stimulate focus formation and intercellular communication. Oncogene, 6: 1151-1159, 1991.
33. Wong, S. T., Winchell, L. F., McCune, B. K., Earp, H. S., Teixodo, J., Massague, J., Herman, B., and Lee, D. C. The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell, 56: 495-506, 1989.
34. Kranenburg, O., van der Eb, A. J., and Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15: 46-54, 1996.
35. Sears, R., Ohtani, K., and Nevins, J. R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell. Biol., 17: 5227-5235, 1997.
36. Keyomarsi, K., Conte, D., Toyofuku, W., and Fox, M. P. Deregulation of cyclin E in breast cancer. Oncogene, 11: 941-950, 1995.
37. Kitahara, K., Yasui, W., Kuniyasu, H., Yokozaki, H., Akama, Y., Yunotani, S., Hisatsugu, T., and Tahara, E. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int. J. Cancer, 62: 25-28, 1995.
38. Tönjes, R. R., Löhler, J., O'Sullivan, J. F., Kay, G. F., Schmidt, G. H., Dalemans, W., Pavirani, A., and Paul, D. Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice. Oncogene, 10: 765-768, 1995.
39. Santoni-Rugiu, E., Preisegger, K. H., Kiss, A., Audolfsson, T., Shiota, G., Schmidt, E. V., and Thorgeirsson, S. S. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc. Natl. Acad. Sci. USA, 93: 9577-9582, 1996.
40. Wolowiec, D., Benchaib, M., Pernas, P., Deviller, P., Souchier, C., Rimokh, R., Felman, P., Bryon, P. A., and French, M. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia (Baltimore), 9: 1382-1388, 1995.